Yomesan 500 mg Chewable tablet

    Yomesan 500 mg Chewable tablet

    S0
    PDF Leaflet Revision Date: 17 January 2022

    API: Niclosamide | Company: Bayer

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of tapeworm infections.

    Dosage (summary)

    Adults: 4 chewable tablets on Day 1; Children: 1-2 tablets based on age.

    Special Populations

    • Hepatic impairment
    • Renal impairment
    • Children

    Pregnancy & Breastfeeding

    Use in pregnancy only if strictly indicated; unknown if excreted in breast milk.

    Key Drug Interactions

    • Alcohol may enhance absorption

    Contraindications

    • Hypersensitivity to niclosamide

    Common side effects

    • Dizziness
    • Nausea
    • Vomiting
    • Rash

    Counselling Points

    • Chew tablets thoroughly before swallowing
    • Drink acidic juice to aid elimination
    • Use saline laxative for Taenia solium infections

    Serious warnings

    • May impair ability to drive or operate machinery
    Important Disclaimer

    The Yomesan 500 mg Chewable tablet professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn